The Food and Drug Administration has approved a new drug called Apretude, the first injectable option for HIV pre-exposure prophylaxis, also called PrEP. According to Healthline, the drug is injected every two months to reduce the risk of sexually-acquired HIV.
Apretude may be a promising alternative to other PrEP regimens, which consist of daily oral medication. One physician believes that for individuals who forget to take daily medications or prefer not to, an appointment every two months for an injection will be easier and more effective.
Rick Good spent ten years in the newspaper business, including with The News & Observer (Raleigh, NC) and The Greenville News (Greenville, SC). He co-wrote, with Melinda Coleman, Rutledge to Riley: Governors of South Carolina, 1776–Present (Published by The Greenville News), and is the author of Mind Games Trivia #1 (Amazon). He has recently spent 15 years creating original trivia content through Sounds Good Mobile Entertainment and continues that with his new company, SGME Software. He edits The Smart Reader’s money, real estate, and business coverage.
